ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Weekly Digest

NVDA Meltdown, DraftKings Wreckage, and a $6.9B Hilton Bet: The Week in Short Interest

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 9 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The week in one paragraph: A coordinated wave of analyst downgrades hit NVDA from at least eight firms, dragging its stock down 24% in a month and sparking a retail attention spike that ORTEX tracked in real time. DKNG collapsed 21% in a single session after an earnings miss, drawing simultaneous cuts from JPMorgan, Wells Fargo, UBS and Stifel. Meanwhile, short sellers split sharply by sector: they piled into financial services, gaming and certain tech names, while covering fast in healthcare, some energy names and homebuilders where deal flow reshapes the picture. With the Nasdaq-100 annual reshuffle rank date on 30 November, index mechanics are already moving prices weeks before any announcement.


Top Short Interest Movers

TIGO posted the sharpest move of the week. Short interest surged 40% in seven days to 1.74% of float, its steepest climb since early October. The move came alongside a UBS upgrade to Neutral, flagged in ORTEX convergence data, and accompanied a week of heavy SI volatility.

LPLA also saw SI jump 40% in one week to 3.8% of float. A single-day 10.6% surge on 12 November drove most of the move. No mitigating factor was visible in availability: short sellers built this position with conviction.

ASST SI rose 20% to 2.96% of free float. Cost to borrow jumped 53% on the week to 1.41%, a sign of active positioning. Availability at 111% remains ample, so covering pressure is limited despite elevated utilization of 52%.

On the other side, WMG SI dropped 28% to 4.9% of float. Availability soared to 8,606% of estimated shorts and the cost to borrow fell to 0.42%, meaning conditions were simply too cheap to maintain a short book. GIL fell 23% to 2.42% of float and CTSH dropped 22% to 4.6%, the latter coinciding with a Deutsche Bank downgrade to Hold and a price target cut to $66 from $75.

AD cut its SI by 26.8% to 2.1% of float, with cost to borrow easing to 0.58%. ORTEX's separate trader note flagged AD shorts at a one-year low as the week closed.


Notable Analyst Activity

NVDA dominated. Baird cut its rating to Neutral from Outperform and slashed its target 60% to $200. Bernstein cut to Market Perform from Outperform, target halved to $200. Evercore ISI dropped to In-Line with a target of $186, down from $465. William Blair, StoneX, Truist, Melius and Craig-Hallum all moved to Hold or equivalent ratings in the same week. Truist's target fell to $174 from $346. The stock is down 24% in one month. Consensus remains Buy with a $302 mean target, but that number is under pressure from every direction.

DKNG drew the second-heaviest analyst traffic. JPMorgan cut to Neutral, target $21 from $30. UBS moved to Neutral, target cut 54% to $22. Wells Fargo went to Equal-Weight, target $21 from $30. Stifel cut first to Hold with a $21 target. By Friday, nine analysts had cut forecasts for the week.

Upgrades that stood out: AMD received back-to-back upgrades from Oppenheimer (to Outperform, $600 target) and William Blair (to Outperform). RSG was lifted to Overweight by JP Morgan with a $295 target, then separately to Buy by Argus Research. PANW was upgraded to Overweight with a $380 target as the stock sat 20% below its recent high. RIOT got a $28 target from Jefferies, implying 115% upside from $13, though Keefe Bruyette downgraded it to Market Perform the following day as the stock had already climbed 29% on the week.

CAPR was upgraded to Buy by Jones Trading with a $25 target, ahead of an FDA decision on deramiocel on 22 November.

DFH was downgraded to Neutral by Zelman and Associates. The stock fell 8.2% on the day. Short interest stands at 30.1% of free float.


Options and Sentiment Shifts

The healthcare sector ETF XLV put-call ratio spiked to 2.20, the highest reading since June. The signal fired on 9 November and was still unresolved by mid-week, with options traders turning defensive even as the short cover rally stalled.

AMP registered consecutive extreme readings. Its PCR hit 0.78 on 10 November, 4.18 standard deviations above its 20-day mean. By 11 November that had climbed to 1.21, nearly 4 standard deviations above the mean. Persistent options-market bearishness in a financial services name that had no obvious news catalyst is the kind of signal worth watching.

CON PCR exploded to 1.12, 4.4 standard deviations above its 20-day mean of 0.078. The reading marked the highest protective-put buying imbalance in over a year for that name.

On the bullish side, APD PCR crashed to 0.53, 4.0 standard deviations below its mean and the lowest in 52 weeks. Unusual call positioning as the stock climbed toward analyst targets. BKD PCR plunged to 0.1283, the lowest on record and 4.2 standard deviations below its mean: extreme bullish options positioning. CCSI also hit a 52-week low in its PCR ahead of earnings.


Sector Themes

Technology and semiconductors under sustained pressure. The SOXX semiconductor ETF sat with short interest at 86.9% of float by mid-week, following a week of extreme swings in which the ETF dropped 71% at one point. SOXL shorts retreated but the borrow market stayed tight. The IXN global technology options signal was the sharpest defensive turn in a year. XLK puts spiked as the selloff deepened. NVDA's downgrade cascade ran across eight separate firms in four days.

Energy names face diverging positioning. COP was cut by both Freedom Broker and Bernstein in the same week, with targets ranging from $122 to $138. DVN was downgraded to Market Perform by Bernstein, target cut to $44 from $49. FANG was cut to Market Perform with a 13% target reduction. At the same time, DK was upgraded to Buy even as short interest surged 23.5% in a single day to 14.5% of float, its highest in months.

Homebuilders and housing remain deeply shorted. DFH carries 30.1% short interest of free float, among the heaviest in US homebuilding. Its Zelman downgrade added to pressure. LOW was cut to Sell by Stifel. FND was cut to Underperform by Evercore ISI with an 18% target reduction.

Bitcoin miners split the room. RIOT surged 29% on the week and drew upgrades, while Hut 8 saw shorts rebuild and analyst targets cut across the board. CleanSpark dropped 19% on the week with shorts digging in.


Convergence Alerts

The most data-rich stories of the week, where three or more pulse types aligned on the same name:

NVDA: Baird downgrade, mass analyst target cuts, retail attention spike, and short interest shifts all hit the same week. The retail Wikipedia and ORTEX page traffic attention indicator spiked sharply. This is not a standard post-earnings correction. Eight separate firms moved their ratings in four trading days.

DKNG: Short interest, analyst activity and options signals converged. ORTEX flagged DraftKings as the most shorted name in its peer group. Four analyst downgrades landed in 48 hours after the earnings miss. The stock is down 21% from its pre-earnings close.

ABNB: Shorts exited, options fear rose, and borrow cost surged simultaneously. Rothschild upgraded to Neutral from Sell with a 41% price target lift to $190, almost exactly at the stock price. Three distinct pulse types fired.

ARM: Three signals pointed the same way after the earnings drop. Shorts unwound after a brutal earnings session, but convergence on a name with structural index exposure adds a mechanical element to the story.

LLY: Short sellers hit a 12-month low while retail attention spiked. Bears are retreating after a blowout quarter, and the positioning picture is clean.

SAP: JP Morgan upgraded to Overweight from Neutral. ORTEX showed a sharp short exit meeting the upgrade. SAP shorts were halved on the week even as borrow costs kept climbing.


What the Real Economy Said

ORTEX Alt Data tracked a record for New Zealand retail electricity connections in October 2026. The NZ electricity share dataset registered 2,377,589 connections, the highest reading since the series began in 2011, topping the previous best of 2,374,895. No single equity flows directly from this reading, but it reflects sustained residential demand growth in that market.

The Consumer credit dataset, drawing on SEC ABS trustee filings, showed delinquencies in Porsche-linked ABS trusts sitting 0.8 standard deviations below their own history as of late October 2026. Nissan's ABS trust delinquencies were similarly 0.8 standard deviations below their own history as of 27 October 2026. Both readings show consumer credit quality in auto ABS remaining stable, relevant context for auto sector shorts that built this week.

Korea air cargo traffic data from the same alt data layer showed American Airlines carrying 775 tonnes from Korea in October, its highest reading in the three-year series history.

Taiwan monthly revenue data flagged Kuo Yang Construction with revenue growth running 1.7 standard deviations above its own history as of 14 November 2026.

Index Rebalance Radar: The Nasdaq-100 annual reshuffle is the dominant mechanical story. The rank date is 30 November, with announcement on 11 December. ORTEX puts HLT at 97% probability of addition, implying $6.9B of forced buying over 10.4 days of volume. KMB sits at 94% probability and $5.6B of forced buying. ALNY is 94% likely to exit, forcing $1.8B of selling. The closest live call is ODFL: ORTEX puts its deletion probability at 55%, with $3.0B of forced selling at stake. The price that decides it is $182.18. It currently trades 4.4% below the exit line. Past Nasdaq-100 additions have moved a median of -3.5% from announcement to effective, on 7.4 times normal trade-day volume.

LXFR exits the Russell 2000 and Russell 3000 tomorrow (trade date 17 November, estimated effective 18 November) following the confirmed Wynnchurch Capital acquisition. Past Russell 2000 deletions of this type have traded at 9 times normal volume on the trade day, with a median move of -4.3% from announcement to effective, a direction that played out 80% of the time across 352 past changes.

The Transocean acquisition of VAL carries a 93% completion probability and would force $742M of S&P MidCap 400 selling over 8.9 days of volume, with an index announcement expected around 30 November.


Stocks to Watch Next Week

NVDA: Eight analyst downgrades in one week, retail attention spiking, earnings still ahead. The gap between the $302 consensus target and current price is widening from both ends.

CAPR: FDA decision on deramiocel due 22 November. Jones Trading upgrade to Buy with $25 target. Shorts trimming into the event. ORTEX index deletion clock also active.

ODFL: At 55% probability of Nasdaq-100 deletion with $3.0B of forced selling at stake. The price that decides it is $182.18, 4.4% above current levels.

DFH: 30.1% short interest of free float, fresh analyst downgrade, and stock down 11.6% on the week. One of the most shorted US homebuilders heading into a difficult rate environment.

DKNG: Most shorted in its peer group per ORTEX convergence data. Nine analyst cuts in a week. The question is whether the new $21 to $22 consensus target acts as a floor or a ceiling.

HLT: At 97% Nasdaq-100 addition probability with $6.9B of forced buying expected. The rank date is 30 November. Positioning ahead of announcement is already active.

LPLA: A 40% single-week SI surge with no visible catalyst beyond the data. Worth monitoring for further build or reversal.

Stocks in this article

How this article was generated

Generated
16 Nov 2026, 13:19
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.